Latest Metapneumovirus Stories
AUSTIN, Texas, July 19, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG Respiratory Viral Panel FAST (RVP FAST).
Researchers at the University of Warwick, and the Kenya Medical Research Institute, Kilifi, Kenya, have found that respiratory syncytial virus (RSV) appears to be the predominant virus detected among infants and children hospitalized in Kenya with severe pneumonia.
SAN DIEGO, Nov.
SAN DIEGO, Oct.
U.S. researchers said on Wednesday that a highly contagious respiratory virus is far more widespread among children than once thought and puts more of them in the hospital than influenza.
A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology.
Diagnostic HYBRIDS announces the release of its D3(R) Ultra 8(TM) DFA Respiratory Virus Screening & Identification Kit for the Canadian market.
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received clearance from Health Canada for its xTAG(TM) Respiratory Viral Panel (RVP).
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, and ViroNovative BV today announced that the companies have signed a licensing agreement that gives Luminex worldwide rights to use ViroNovative's human metapneumovirus (hMPV) intellectual property in the xTAG Respiratory Viral Panel (RVP).